Skip to main content
. 2022 Jun 6;106:103742. doi: 10.1016/j.drugpo.2022.103742

Table 2.

Available safer supply/risk mitigation substances by region.

Available Substance TOTAL
British Columbia
Alberta
Ontario
Québec
Atlantic Provinces
Time point Mar May Mar May Mar May Mar May Mar May Mar May
Opioids 21 81 2 56 0 1 15 17 2 3 2 4
Benzodiazepines 4 24 0 17 0 0 0 1 2 3 2 3
Stimulants 5 56 1 47 0 1 2 2 0 3 0 3
Cannabis 2 14 0 2 0 0 0 9 0 3 0 0
Alcohol 8 27 0 14 0 0 8 9 0 3 0 1
Nicotine products 9 25 0 13 0 0 9 9 0 3 0 0
# of sites 21 81 2 56 0 1 15 17 2 3 2 4

Note: Bold font denotes increases by second scan reference date. Opioids included hydromorphone (Dilaudid, generic, contin), morphine (Kadian, M Eslon), methadone, Sublocade, Suboxone, fentanyl (patch, IV), and oxycodone. Specified benzodiazepines included Lorazepam, Clonazepam, and Diazepam. Specified stimulants included dextroamphetamine and methylphenidate. Alcohol included beer and wine. Nicotine products included nicotine patches and gum, cigarettes, and nicotine cessation medication.